West Pharmaceutical Services (WST) revenue: $3.1B
West Pharmaceutical Services reported $3.1B of revenue for the year ended Dec 31, 2025, up 6.3% from $2.9B a year earlier.
From West Pharmaceutical Services's filings with the SEC · Read the filing · WST stock page
West Pharmaceutical Services revenue by year
#950 of 3,622 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Dec 31, 2025 | $3.1B | +6% |
| Dec 31, 2024 | $2.9B | -2% |
| Dec 31, 2023 | $2.9B | +2% |
| Dec 31, 2022 | $2.9B | +2% |
| Dec 31, 2021 | $2.8B | – |
Revenue of similar companies
Companies in the same industry as West Pharmaceutical Services, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Dexcom | $4.7B | Dec 31, 2025 |
| MiniMed Group | $3.1B | Apr 24, 2026 |
| West Pharmaceutical Services | $3.1B | Dec 31, 2025 |
| Globus Medical | $2.9B | Dec 31, 2025 |
| Insulet | $2.7B | Dec 31, 2025 |
| Icu Medical | $2.2B | Dec 31, 2025 |
| Teleflex | $2B | Dec 31, 2025 |
Questions and answers
What is West Pharmaceutical Services's revenue?
West Pharmaceutical Services reported $3.1B of revenue for the year ended Dec 31, 2025, up 6.3% from $2.9B a year earlier.
Numbers as reported in West Pharmaceutical Services's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology